Tarsus Pharmaceuticals, Inc. (TARS)

NASDAQ: TARS · Real-Time Price · USD

82.76

+8.71 (11.76%)

At close: Sep 2, 2026, 4:00 PM EDT

82.39

-0.37 (-0.45%)

Pre-market: Sep 3, 2026, 7:14 AM EDT

Tarsus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	3,632	3,476	2,117	670	391	465
Market Cap Growth	46.86%	64.21%	215.74%	71.44%	-15.95%	-44.60%
Enterprise Value	3,271	3,156	1,873	455	185	283
Last Close Price	82.76	81.88	55.37	20.25	14.66	22.50

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	97.48	-	-	-	-
PS Ratio	5.99	7.70	11.57	38.42	15.15	8.16
PB Ratio	10.33	10.12	9.43	3.40	2.03	2.79
P/TBV Ratio	10.69	10.34	9.79	3.47	2.03	2.79
P/FCF Ratio	64.85	-	-	-	-	147.13
P/OCF Ratio	48.97	-	-	-	-	124.13

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	5.39	6.99	10.24	26.10	7.15	4.96
EV/FCF Ratio	58.41	-	-	-	-	89.41

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.26	0.24	0.32	0.15	0.10	0.01
Debt / FCF Ratio	1.59	-	-	-	-	0.38
Net Debt / Equity Ratio	-1.04	-0.97	-0.97	-1.00	-1.02	-1.02
Net Debt / EBITDA Ratio	7.81	4.83	1.83	1.39	3.16	14.40
Net Debt / FCF Ratio	-6.44	14.98	2.59	1.66	3.97	-53.96
Asset Turnover	1.10	0.96	0.57	0.07	0.13	0.33
Inventory Turnover	25.47	27.18	23.12	-	-	-
Quick Ratio	3.12	3.72	4.21	6.64	14.30	14.98
Current Ratio	3.20	3.85	4.43	6.93	14.61	15.33
Return on Equity (ROE)	-13.68%	-23.39%	-54.83%	-69.71%	-34.53%	-8.31%
Return on Assets (ROA)	-5.49%	-9.45%	-23.46%	-36.27%	-19.27%	-4.33%
Return on Capital Employed (ROCE)	-11.10%	-16.60%	-40.70%	-62.60%	-29.50%	-7.30%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-1.28%	-1.91%	-5.46%	-20.27%	-15.88%	-2.97%
FCF Yield	1.54%	-0.64%	-4.00%	-17.75%	-12.67%	0.68%
Buyback Yield / Dilution	-7.95%	-11.11%	-27.98%	-19.35%	-19.78%	-231.12%

SEC Filings: 10-K · 10-Q